| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |